What’s new at Hadasit

Filter by:

Articles

Immunyx Pharma won 1st place in Catapult competition of the EIT Health

Hadassah Center for Psychedelic Research: Psilocybin Could Be Effective OCD Treatment

EMRIS Pharma Launches the Development of a New Innovative topical drug for the Treatment of Skin Toxicities

Pathkeeper received FDA clearance for the spinal surgery navigation system

Israeli universities and hospitals churn out startups as ties with tech industry grow

Hadasit’s portfolio company NeuroGenesis receives FDA clearance for Phase IIb study

Gamida Cell receives FDA approval for blood cancer therapy, developed in collaboration with Prof. Amnon Peled, Hadassah

P-Cure’s Prothon therapy deployed in collaboration with Hadassah Medical Center received FDA clearance

January 23, 2023

Hadassah Portfolio Company Immunyx Pharma Selected to Join BLUE KNIGHT™

December 02, 2022

Hadassah scientists derived male and female cells from same person for the first time in the world

October 20, 2022

Exosomm reaches Calcalist and Tnuva’s FoodTech competition final stage

August 17, 2022

Hadasit portfolio company Enlivex Therapeutics has received approval for initiation the multicenter Phase I/II Trial of Allocetra

18.10.23. Smart Hospital: Digital Infrastructure and Patient Data Collaborations

Hadassah BioMed Innovation Day : 30th of May 2023

September 21, 2022

Hadasit conference: “Money talks! Early stage funding in the biomed sector: Pahama Hall, Hadasssah Ein Kerem, Jerusalem

Hadassah Accelerator’s Class #3 is open for applications : BioHouse, Hadassah Ein Karem, Jerusalem

Hadasit spring seminar “Algorithms and AI Tools as Commercial Assets in the Biomedical Domain”: Biohouse, Hadassah Ein kerem

December 24, 2021

Hadasit Webinar: Health Tech Wish List – Data, Needs & Funding: Zoom Meeting

December 21, 2021

Hadasit conference: “Exploring the Challenges of Preclinical Studies. Academic/Clinical/Industry collaborations” : Hadassah Ein Kerem, Pahama Hall

September 15, 2020

Hadasit AI Webinar – Innovators in digital health – time for some hard learned lessons!

Hadassah Accelerator Demo Day Class 2 : Zoom Meeting

October 24, 2019

Opening ceremony of the new Wohl Institute For Transnational Medicine : Panama Hall, Hadassah Ein Kerem, Jerusalem

October 15, 2018

From Molecule to Drug : Biohouse (Ein Carem Campus)

From B2B: From Bench to Billions : Tourism Auditorium Hadassah Ein-Karem

Newsletter July 2023

Exciting news from Hadasit April 2023

Hadassah scientists derived male and female cells from same person for the first time in the world

Groundbreaking discovery at Hadassah may change the practice of treating pregnant women, fetuses, and newborns with CMV

February 28, 2022

The Journey from Bench to Market: Human Embryonic Stem Cells at Hadassah

January 12, 2022

Behind the scenes of Hadassah and PathKeeper collaboration on Spinal Surgery Navigation system

August 11, 2021

Imaging services for preclinical studies at the WOHL Institute